Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)

NCT02787070 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT02787070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02787070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)
Lead sponsor
Menzies School of Health Research
Phase
Phase 4
Overall status
Completed
Start date
September 14, 2016
Completion date
November 30, 2018
Enrollment
420 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated malaria